Search research articles
Contact Us
Filters
Showing results (1-10 of 31) with videos related to
Page
of 4
Sort By:
European Review for Medical and Pharmacological Sciences
|
March 25, 2016
Urate lowering therapies in the treatment of gout: a systematic review and meta-analysis
C Borghi, F Perez-Ruiz
European Review for Medical and Pharmacological Sciences
|
May 26, 2015
Hyperuricemia and tissue monourate deposits: prospective therapeutic considerations
F Perez-Ruiz, L Punzi
Scandinavian Journal of Rheumatology
|
April 17, 2008
Management of gout
F Perez-Ruiz, N Schlesinger
Current Medical Research and Opinion
|
April 25, 2013
Serum uric acid and metabolic risk
P Richette, F Perez-Ruiz
Current Medical Research and Opinion
|
September 29, 2015
Inflammation: a possible mechanism for a causative role of hyperuricemia/gout in cardiovascular disease
F Perez-Ruiz, M A Becker
Journal of Clinical Gastroenterology
|
August 26, 1998
Nodular regenerative hyperplasia of the liver and antiphospholipid antibodies
F Perez-Ruiz, A C Zea-Mendoza
European Review for Medical and Pharmacological Sciences
|
October 14, 2017
Potency on lowering serum uric acid in gout patients: a pooled analysis of registrative studies comparing febuxostat vs. allopurinol
M Cutolo, M A Cimmino, F Perez-Ruiz
Annals of the Rheumatic Diseases
|
November 26, 1997
Gouty arthritis in the manubriosternal joint
F Perez-Ruiz, M Calabozo, A Alonso-Ruiz
Journal of Medical Economics
|
February 9, 2016
Cost-effectiveness analysis of febuxostat in patients with gout in Spain
F Perez-Ruiz, C Díaz-Torné, D Carcedo
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
November 24, 2007
Optimisation of the treatment of acute gout
F Perez-Ruiz, F J Mielgo, A M Beites
Page
of 4
Search research articles
Search
Showing results (1-10 of 31) with videos related to
Sort By:
Page
of 4
European Review for Medical and Pharmacological Sciences
|
March 25, 2016
Urate lowering therapies in the treatment of gout: a systematic review and meta-analysis
C Borghi, F Perez-Ruiz
European Review for Medical and Pharmacological Sciences
|
May 26, 2015
Hyperuricemia and tissue monourate deposits: prospective therapeutic considerations
F Perez-Ruiz, L Punzi
Scandinavian Journal of Rheumatology
|
April 17, 2008
Management of gout
F Perez-Ruiz, N Schlesinger
Current Medical Research and Opinion
|
April 25, 2013
Serum uric acid and metabolic risk
P Richette, F Perez-Ruiz
Current Medical Research and Opinion
|
September 29, 2015
Inflammation: a possible mechanism for a causative role of hyperuricemia/gout in cardiovascular disease
F Perez-Ruiz, M A Becker
Journal of Clinical Gastroenterology
|
August 26, 1998
Nodular regenerative hyperplasia of the liver and antiphospholipid antibodies
F Perez-Ruiz, A C Zea-Mendoza
European Review for Medical and Pharmacological Sciences
|
October 14, 2017
Potency on lowering serum uric acid in gout patients: a pooled analysis of registrative studies comparing febuxostat vs. allopurinol
M Cutolo, M A Cimmino, F Perez-Ruiz
Annals of the Rheumatic Diseases
|
November 26, 1997
Gouty arthritis in the manubriosternal joint
F Perez-Ruiz, M Calabozo, A Alonso-Ruiz
Journal of Medical Economics
|
February 9, 2016
Cost-effectiveness analysis of febuxostat in patients with gout in Spain
F Perez-Ruiz, C Díaz-Torné, D Carcedo
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
November 24, 2007
Optimisation of the treatment of acute gout
F Perez-Ruiz, F J Mielgo, A M Beites
Page
of 4